A clinical pharmacist has to have deeper understanding of medications and their therapeutic effects since the pharmaceutical treatment regimen is a continual process. The patient's healthcare outcomes are improved through pharmaceutical care plans, which also help medical practitioners avoid illness. The pharmaceutical care plan is very important in helping stroke patients discover Drug Related Problems (DRPs), which include neglected symptoms, sub-therapeutic dosages, high dosages, drug usage without a clear diagnosis, refusal to take medications, inappropriate drug choice, drug reactions, and adverse drug responses. There is significant proof that supports the clinical pharmacist's assistance in the treatment of stroke patients, and studies assessing pharmacist treatments in stroke patients have been reported in the literature. Explaining the specific evidence of pharmacist treatments on stroke patients is the goal of this study.